Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Octapeptide derived from activity-dependent neu...
Semi-synthetic vinca alkaloid from Catharanthus...
CDK2/4/6 inhibitor
PI3K and mTOR inhibitor.
Endogenous peptide, involved in stress signalin...
Macrolide; peptidyl transferase inhibitor, prot...
R,R enantiomer of formoterol; β2-adrenergic an...
L-isomer of cetirizine; histamine H1 antagonist...
Endogenous steroid hormone, estradiol metabolit...
Laminin-derived nonapeptide.
Aldose reductase inhibitor.
Prodrug of the compound mycophenolic acid.
JAK1/2/3 inhibitor.
Nucleoside (adenosine) analog; viral DNA polyme...
Alkylamine; histamine H1 antagonist, SERT and N...
Hydroxycinnamic acid found in coffee, argan oil...
Thrombin inhibitor.
Hedgehog and Smo agonist.